Financial statements Bio-Lab

Balance sheet of Bio-Lab

Company age:
Age:
12 y. 11 m. 18 d.
Share capital:
Share capital:
20 000 PLN

Balance sheet data of BIO-LAB

Year
2018
2019
2020
2021
2022
2023
Total assets 167 862,00 133 963,13 91 065,17 1 501 792,11 197 618,26 172 240,58
A. Fixed assets 0,00 0,00 0,00 0,00 0,00 0,00
B. Current assets 167 862,00 133 963,13 91 065,17 1 501 792,11 197 618,26 172 240,58
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 167 862,00 133 963,13 91 065,17 1 501 792,11 197 618,26 172 240,58
A. Equity -9 689,59 3 081,97 23 141,61 49 870,35 34 120,40 33 600,33
B. Liabilities and provisions for liabilities 177 551,59 130 881,16 67 923,56 1 451 921,76 163 497,86 138 640,25
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.